"Eleven clinical trials that will shape medicine in 2026" - BriaCell Phase 3 Trial Featured in Nature Medicine Biotech Investing
NRx Pharmaceuticals announces elimination of all balance sheet debt following equity conversion Life Science Investing
Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson's Disease Life Science Investing
Incyte Announces European Commission Approval of Minjuvi® for the Treatment of Relapsed or Refractory Follicular Lymphoma Life Science Investing
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment Life Science Investing
Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer's Clinical Trial Life Science Investing
BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S in Women with Hormone Receptor Positive/HER2 Negative Stage II-III Breast Cancer Life Science Investing
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D Life Science Investing
Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference Life Science Investing
